Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Psoriasis: from Pathogenesis to Targeted Therapies.
Conrad C, Gilliet M. Conrad C, et al. Among authors: gilliet m. Clin Rev Allergy Immunol. 2018 Feb;54(1):102-113. doi: 10.1007/s12016-018-8668-1. Clin Rev Allergy Immunol. 2018. PMID: 29349534 Review.
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Gilliet M, Conrad C, Geiges M, Cozzio A, Thürlimann W, Burg G, Nestle FO, Dummer R. Gilliet M, et al. Arch Dermatol. 2004 Dec;140(12):1490-5. doi: 10.1001/archderm.140.12.1490. Arch Dermatol. 2004. PMID: 15611427
Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M. Nestle FO, et al. Among authors: gilliet m. J Exp Med. 2005 Jul 4;202(1):135-43. doi: 10.1084/jem.20050500. J Exp Med. 2005. PMID: 15998792 Free PMC article.
Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha.
Nestle FO, Gilliet M. Nestle FO, et al. Among authors: gilliet m. J Invest Dermatol. 2005 Nov;125(5):xiv-xv. doi: 10.1111/j.0022-202X.2005.23923.x. J Invest Dermatol. 2005. PMID: 16297178 No abstract available.
The pathogenic role of tissue-resident immune cells in psoriasis.
Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. Boyman O, et al. Among authors: gilliet m. Trends Immunol. 2007 Feb;28(2):51-7. doi: 10.1016/ Epub 2007 Jan 2. Trends Immunol. 2007. PMID: 17197238
Type I IFNs at the interface between cutaneous immunity and epidermal remodeling.
Conrad C, Gilliet M. Conrad C, et al. Among authors: gilliet m. J Invest Dermatol. 2012 Jul;132(7):1759-62. doi: 10.1038/jid.2012.149. J Invest Dermatol. 2012. PMID: 22695287
Anti-TNF therapy in the treatment of psoriasis in a patient with acute-on-chronic pancreatitis.
Clayton H, Flatz L, Vollenweider-Roten S, Schoepfer A, Gilliet M, Conrad C. Clayton H, et al. Among authors: gilliet m. Dermatology. 2013;227(3):193-6. doi: 10.1159/000351714. Epub 2013 Oct 31. Dermatology. 2013. PMID: 24192530
Immune sensing of nucleic acids in inflammatory skin diseases.
Demaria O, Di Domizio J, Gilliet M. Demaria O, et al. Among authors: gilliet m. Semin Immunopathol. 2014 Sep;36(5):519-29. doi: 10.1007/s00281-014-0445-5. Epub 2014 Sep 16. Semin Immunopathol. 2014. PMID: 25224103 Review.
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA.
Lande R, Chamilos G, Ganguly D, Demaria O, Frasca L, Durr S, Conrad C, Schröder J, Gilliet M. Lande R, et al. Among authors: gilliet m. Eur J Immunol. 2015 Jan;45(1):203-13. doi: 10.1002/eji.201344277. Epub 2014 Nov 13. Eur J Immunol. 2015. PMID: 25332209
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.
Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S, Vence L, Riccieri V, Guillaume P, Navarini AA, Romero P, Costanzo A, Piccolella E, Gilliet M, Frasca L. Lande R, et al. Among authors: gilliet m. Nat Commun. 2014 Dec 3;5:5621. doi: 10.1038/ncomms6621. Nat Commun. 2014. PMID: 25470744
112 results
Jump to page